Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Optigenex
Its shares trade under the ticker OPGX. It has been listed since 15 April 2005. In the fiscal year to 31 December 2010, it reported revenue of $991,250 and a net loss of $685,132. At that date it held total assets of $1.9m and shareholders' equity of −$3.7m.
Optigenex, Inc. is engaged in the manufacturing and licensing of beauty, dietary supplements and personal care products. The company is headquartered in Melissa, Texas. The company went IPO on 2005-04-15. The firm is focused on healthy age management. The firm is a provider of dietary supplements, skin care products and bulk ingredients. The firm formulates, licenses and markets its own natural cellular deoxyribonucleic acid (DNA) care ingredient known as AC-11. The AC-11 is a bioactive and water-soluble rainforest ingredient derived from the medicinal herb Uncaria tomentosa. The firm's customers include manufacturers, distributors and retailers across the world in the dietary supplement and anti-aging topical skin care, cosmetic and cosmeceutical market categories. The firm's product, AC-11, enhances the natural DNA repair processes. AC-11 is sold for ingestible use and topical application. In topical applications, it is known under the brand name AC-11. AC-11 is listed under its International Nomenclature of Cosmetics Ingredients (INCI) names Maltodextrin and C1-8 Alkyl Tetrahydroxycyclohexanoate.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Materials
- Industry
- Chemicals
- Listed since
- 15 Apr 2005
- Employees
- 1
- Website
- optigenex.com ↗
Leadership
Pay as last reported
- William WaltersChairman of the Board, since 2002
- Daniel ZwirenPresident, Chief Executive Officer, Chief Financial Officer$140,000
- Mr. Michael MullarkeyDirector
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Optigenex Inc possesses several strengths that contribute to its success in the market. Firstly, the company has a strong portfolio of high-quality products that are reliable and efficient. These products have gained a positive reputation among customers and have helped establish a loyal customer base. Furthermore, Optigenex Inc benefits from a well-established distribution network, allowing for widespread availability of its offerings.
Weaknesses
- Despite its strengths, Optigenex Inc also faces certain weaknesses. One major weakness is the company's limited market presence. Optigenex Inc primarily operates within a specific niche, which may limit its growth potential. Additionally, the company could benefit from enhancing its brand awareness and marketing efforts to increase visibility and attract a wider customer base.
Opportunities
- In terms of opportunities, Optigenex Inc has the potential to expand its product offerings to cater to a larger market. By diversifying its product line, the company can tap into new customer segments and increase its market share. Furthermore, the growing trend of health and wellness presents an excellent opportunity for Optigenex Inc to develop and promote new products that align with consumer demands.
Threats
- Optigenex Inc must also be aware of potential threats that could impact its business. One key threat is the presence of strong competitors in the market. These competitors may have established brand names and larger market shares, making it crucial for Optigenex Inc to continuously innovate and differentiate itself from the competition. Moreover, external factors such as changing regulations or economic instability could pose challenges to the company's operations.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.